vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and AMERICAN AXLE & MANUFACTURING HOLDINGS INC (AXL). Click either name above to swap in a different company.
AMERICAN AXLE & MANUFACTURING HOLDINGS INC is the larger business by last-quarter revenue ($1.4B vs $829.0M, roughly 1.7× Acadia Healthcare Company, Inc.). Acadia Healthcare Company, Inc. runs the higher net margin — 0.5% vs -5.4%, a 6.0% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs 0.2%). Over the past eight quarters, Acadia Healthcare Company, Inc.'s revenue compounded faster (2.0% CAGR vs -7.2%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
American Axle & Manufacturing, Inc. (AAM), headquartered in Detroit, Michigan, is an American manufacturer of automobile driveline and drivetrain components and systems.
ACHC vs AXL — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $1.4B |
| Net Profit | $4.5M | $-75.3M |
| Gross Margin | — | 10.2% |
| Operating Margin | — | -2.4% |
| Net Margin | 0.5% | -5.4% |
| Revenue YoY | 7.5% | 0.2% |
| Net Profit YoY | -50.8% | -449.6% |
| EPS (diluted) | $0.05 | $-0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $1.4B | ||
| Q3 25 | $851.6M | $1.5B | ||
| Q2 25 | $869.2M | $1.5B | ||
| Q1 25 | $770.5M | $1.4B | ||
| Q4 24 | $774.2M | $1.4B | ||
| Q3 24 | $815.6M | $1.5B | ||
| Q2 24 | $796.0M | $1.6B |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $-75.3M | ||
| Q3 25 | $36.2M | $9.2M | ||
| Q2 25 | $30.1M | $39.3M | ||
| Q1 25 | $8.4M | $7.1M | ||
| Q4 24 | $32.6M | $-13.7M | ||
| Q3 24 | $68.1M | $10.0M | ||
| Q2 24 | $78.5M | $18.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | 10.2% | ||
| Q3 25 | — | 12.6% | ||
| Q2 25 | — | 13.1% | ||
| Q1 25 | — | 12.3% | ||
| Q4 24 | — | 11.2% | ||
| Q3 24 | — | 11.4% | ||
| Q2 24 | — | 13.3% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | -2.4% | ||
| Q3 25 | 4.7% | 3.2% | ||
| Q2 25 | 5.8% | 3.6% | ||
| Q1 25 | 1.7% | 3.0% | ||
| Q4 24 | 4.9% | 2.6% | ||
| Q3 24 | 12.1% | 2.8% | ||
| Q2 24 | 13.4% | 5.3% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | -5.4% | ||
| Q3 25 | 4.3% | 0.6% | ||
| Q2 25 | 3.5% | 2.6% | ||
| Q1 25 | 1.1% | 0.5% | ||
| Q4 24 | 4.2% | -1.0% | ||
| Q3 24 | 8.4% | 0.7% | ||
| Q2 24 | 9.9% | 1.1% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $-0.62 | ||
| Q3 25 | $0.40 | $0.07 | ||
| Q2 25 | $0.33 | $0.32 | ||
| Q1 25 | $0.09 | $0.06 | ||
| Q4 24 | $0.36 | $-0.11 | ||
| Q3 24 | $0.74 | $0.08 | ||
| Q2 24 | $0.85 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $708.9M |
| Total DebtLower is stronger | $2.5B | $4.0B |
| Stockholders' EquityBook value | $2.0B | $640.0M |
| Total Assets | $5.5B | $6.7B |
| Debt / EquityLower = less leverage | 1.29× | 6.31× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $708.9M | ||
| Q3 25 | $118.7M | $714.1M | ||
| Q2 25 | $131.4M | $586.5M | ||
| Q1 25 | $91.2M | $549.2M | ||
| Q4 24 | $76.3M | $552.9M | ||
| Q3 24 | $82.1M | $542.5M | ||
| Q2 24 | $77.2M | $519.9M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $4.0B | ||
| Q3 25 | $2.3B | $2.6B | ||
| Q2 25 | $2.3B | $2.6B | ||
| Q1 25 | $2.2B | $2.6B | ||
| Q4 24 | $2.0B | $2.6B | ||
| Q3 24 | $1.9B | $2.6B | ||
| Q2 24 | $1.8B | $2.7B |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $640.0M | ||
| Q3 25 | $3.1B | $718.4M | ||
| Q2 25 | $3.1B | $673.0M | ||
| Q1 25 | $3.0B | $596.3M | ||
| Q4 24 | $3.1B | $562.8M | ||
| Q3 24 | $3.0B | $616.3M | ||
| Q2 24 | $3.0B | $609.6M |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $6.7B | ||
| Q3 25 | $6.4B | $5.3B | ||
| Q2 25 | $6.3B | $5.3B | ||
| Q1 25 | $6.1B | $5.1B | ||
| Q4 24 | $6.0B | $5.1B | ||
| Q3 24 | $5.9B | $5.3B | ||
| Q2 24 | $5.7B | $5.3B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 6.31× | ||
| Q3 25 | 0.74× | 3.61× | ||
| Q2 25 | 0.74× | 3.86× | ||
| Q1 25 | 0.72× | 4.38× | ||
| Q4 24 | 0.64× | 4.58× | ||
| Q3 24 | 0.62× | 4.28× | ||
| Q2 24 | 0.62× | 4.42× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $120.5M |
| Free Cash FlowOCF − Capex | — | $54.7M |
| FCF MarginFCF / Revenue | — | 4.0% |
| Capex IntensityCapex / Revenue | — | 4.8% |
| Cash ConversionOCF / Net Profit | 13.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $155.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $120.5M | ||
| Q3 25 | $73.2M | $143.3M | ||
| Q2 25 | $133.5M | $91.9M | ||
| Q1 25 | $11.5M | $55.9M | ||
| Q4 24 | $116.7M | $151.2M | ||
| Q3 24 | $163.1M | $143.6M | ||
| Q2 24 | $171.1M | $142.8M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $54.7M | ||
| Q3 25 | $-63.0M | $79.2M | ||
| Q2 25 | $-34.2M | $34.6M | ||
| Q1 25 | $-163.2M | $-13.4M | ||
| Q4 24 | $-86.8M | $73.2M | ||
| Q3 24 | $-27.1M | $70.4M | ||
| Q2 24 | $16.9M | $94.0M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 4.0% | ||
| Q3 25 | -7.4% | 5.3% | ||
| Q2 25 | -3.9% | 2.3% | ||
| Q1 25 | -21.2% | -0.9% | ||
| Q4 24 | -11.2% | 5.3% | ||
| Q3 24 | -3.3% | 4.7% | ||
| Q2 24 | 2.1% | 5.8% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 4.8% | ||
| Q3 25 | 16.0% | 4.3% | ||
| Q2 25 | 19.3% | 3.7% | ||
| Q1 25 | 22.7% | 4.9% | ||
| Q4 24 | 26.3% | 5.6% | ||
| Q3 24 | 23.3% | 4.9% | ||
| Q2 24 | 19.4% | 3.0% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | 15.58× | ||
| Q2 25 | 4.43× | 2.34× | ||
| Q1 25 | 1.37× | 7.87× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | 14.36× | ||
| Q2 24 | 2.18× | 7.85× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
AXL
| Driveline | $748.4M | 54% |
| Other | $345.7M | 25% |
| Metal Forming | $289.8M | 21% |
